The sarcomeric protein a-actinin-3, which is encoded by the ACTN3 gene, interacts with multiple proteins involved in structure, muscle metabolism, and signaling. a-Actinin-3 deficiency caused by a knockout or mutation of the terminator sequence of the ACTN3 gene leads to a change in muscle phenotype from fast-twitch fibers to slow-twitch fibers, resulting in enhanced aerobic metabolic energy, decreased calcium sensitivity, and degraded sprint and power performance. In this study, the singlenucleotide polymorphisms (SNPs) in the equine ACTN3 gene in Yili horses (n ¼ 38) were detected and sequenced. Comparison of the obtained equine ACTN3 sequences with those in GenBank identified 15 SNPs, with one located in the promoter, eight located in exons, and six located in introns. All eight exonic SNPs, except for the missense mutation g.9059T>G, were synonymous. The g.9059T>G mutation lead to an increase in the free energy of the thermodynamic ensemble of the equine ACTN3 mRNA from À1157.84 to À1157.35 kcal/mol and changed the secondary structure of a-actinin-3, which may affect its function. We hypothesized that g.9059T>G might affect athletic performance and may be a candidate SNP for racehorse breeding.
Introduction
a-Actinins are a family of actin-binding proteins that belong to the spectrin superfamily, which includes a and b spectrin and dystrophin [1] , and the characteristics and structures of these proteins are highly conserved. In human and mouse, the sarcomeric a-actinins a-actinin-2 and a-actinin-3, which are encoded by the ACTN2 and ACTN3 genes, respectively, are major components of the contractile apparatus at Z-lines [2] and function in the maintenance of sarcomeric integrity and cytoskeleton structure by generating cross-linkages that anchor the actin filaments of adjoining sarcomeres [3] . Importantly, a-actinin-2 is expressed in all muscle fiber types, whereas a-actinin-3 is only expressed in type 2 (fast glycolytic) muscle fibers, which are required for fast muscle contraction (100% of type IIb/x fibers and 50% of type IIa fibers) [4] . a-Actinins share a common domain topology, and structural analysis revealed inverse parallel dimers in skeletal muscle. a-Actinins contain three functional domains, an actin-binding domain at the N-terminus, which is composed of two pairs of calponin homology domains (CH1 and CH2) [5] ; a central rod domain, consisting of four spectrin repeats [6, 7] ; and the C-terminus, which contains the EF hand domains (EF1/2 and EF3/4), which enable the protein to bind to calcium [8] .
There is evidence that a common stop codon polymorphism in the human ACTN3 gene (R577X) is associated with athletic performance in both athletes and the general population [9e12]. The XX ACTN3 R577X genotype leads to a deficiency of a-actinin-3 in the fast myofibers, resulting in a decrease in the ability of rapid expansion, thereby increasing endurance and decreasing bone mineralization [13] . Del [14] identified factors related to muscle injury and found that the X allele of the ACTN3 gene is beneficial to marathon runners. By contrast, Chiu [15] demonstrated that the RR genotype was associated with significantly improved performance in the first 25 m of a 100 m event in Taiwanese swimmers, especially in women and young men. A mouse study demonstrated that an ACTN3 gene knockout showed reduced holding power but increased antifatigue performance compared with wild-type mice [16] . In addition, muscle physiology may also be affected by ACTN3 gene polymorphisms. Lactate dehydrogenase activity was lower in knockout mice than wild-type mice; however, the activity of key enzymes in various metabolic pathways, including the tricarboxylic acid cycle, electronic signal transmission chain in mitochondria, and fatty acid oxidation was greater [16, 17] . Calcineurin activity in the muscle tissue of knockout mice was greater than that in the muscle tissue of control mice [18] . A deficiency of a-actinin-3 caused by knockout or mutation leads to upregulation of Z-line protein [19] , transformation of fast-twitch fibers into slow-twitch fibers [16] , enhanced (metabolized) aerobic metabolic energy [20] , and altered calcium dynamics via calcium phosphatase signaling [21, 22] , thus affecting athletic performance.
Gu [23] discovered four single-nucleotide polymorphisms (SNPs) in the ACTN3 gene in Thoroughbred horses, and in a study of four French horse breeds (French trotter, French saddlebred, Thoroughbred, and Cob Normand), Mata [24] reported eight SNPs, six in the coding region, which were synonymous mutations, and two in the 3 0 -untranslated region [24] . Thomas identified 34 SNPs in five Australian horse breeds (Thoroughbred, Arabian, Standardbred, Shire, and Clydesdale), of which 26 were intronic and eight were exonic [25] . All eight exonic SNPs were synonymous, and one SNP located in the promoter region affected the expression of ACTN3.
The genes encoding a-actinins play important roles in Thoroughbred breeding [26] . However, previous studies of the ACTN3 gene have mainly focused on the effects of polymorphisms on athletic performance in humans and mice, whereas few studies have investigated the equine ACTN3 gene.
The Yili horse is one of the most important racehorse breeds in China. Therefore, the goals of this study were to determine the diversity of the ACTN3 gene SNPs in the Yili horse and to identify specific SNPs of ACTN3 that may be useful for racehorse breeding.
Methods
All animal care and use procedures were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee at Xinjiang Agricultural University.
Blood Sampling
Blood samples were collected from 38 Yili horses by jugular venipuncture into 5 mL vacuum tubes containing sodium citrate as an anticoagulant and were stored at À20 C until assay. Eighteen of the selected horses were racehorses of the 1,000e2,000 m group, and 12 were of the 3,000e3,600 m group.
PCR and Sequencing
Primers for gene fragment amplification were designed based on the ACTN3 sequence retrieved from GenBank (GenBank accession no. HQ005425) using the Primer-BLAST algorithm (https:// www.ncbi.nlm.nih.gov/tools/primer-blast/). When the interval between two adjacent exons was small (<350 bp), the two exons were amplified with the same primer ( Table 1 ). The designed primers were synthesized by Sangon Biotech (Shanghai) Co, Ltd (Shanghai, China). Deoxyribonucleic acid was extracted from the blood samples using Dzup (Blood) Genomic DNA Isolation Reagent (Sangon Biotech) according to the manufacturer's instructions. After DNA purification, touchdown polymerase chain reaction (PCR) reactions were performed in a 20 mL reaction containing 0.5 mL of 10 mM Forward and 0.5 mL of 10 mM Reverse primer, 10 mL of SanTaq PCR Master Mix (Sangon Biotech), 1 mL of gDNA and 8 mL of H 2 O. All samples were denatured at 95 C for 3 minutes, and then subjected to 10 cycles of denaturation at 94 C for 30 seconds, annealing at 63 C for 45 seconds (with a reduction of 0.5 C for each cycle), and extension at 72 C for 1 minute, followed by 30 cycles of denaturation at 94 C for 30 seconds, annealing at 58 C for 45 seconds, and extension at 72 C for 1 minute. Then, the samples were subjected to a final extension step at 72 C for 10 minutes. The PCR products ranged in size from 427 to 753 bp, and quality was assessed by electrophoresis on a 1.5% agarose gel containing ethidium bromide and tris-acetate-ethylenediaminetetraacetic acid (Sangon Biotech) (Fig. 1) . The products were sequenced with an ABI 3730Âl DAN Analyzer (Applied Biosystems, Carlsbad, CA, USA) by Sangon Biotech.
Statistical Analyses
Single-nucleotide polymorphism loci were identified using the SeqMan II module of the DNASTAR software package (http://www. dnastar.com/t-dnastar-lasergene.aspx). Observed heterozygosity, expected heterozygosity, minor allele frequency, and HardyWeinberg equilibrium were determined for each locus using Haploview 4.2 software. A two-sided Fisher's exact test was performed using SAS 8.1 to assess the significance of differences in the allele frequencies between different groups.
Bioinformatics
The National Center for Biotechnology Information database (https://www.ncbi.nlm.nih.gov/) was used to identify the open reading frame and coding region of the horse ACTN3 gene. Next, the BioXM 2.6 program (http://bioxm.software.informer.com/2.6/) was used to compare the amino acid sequences encoded by mutant genes. Then, RNAfold software (http://rna.tbi.univie.ac.at/cgi-bin/ RNAWebSuite/RNAfold.cgi) was used to predict changes in the secondary structures caused by exon mutations. Finally, the NPSA-PRABI site (https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl? page¼npsa_sopma.html) was used to predict the changes in the secondary structure of the protein caused by the mutations.
Results
Mutation analysis of the Yili horse ACTN3 gene was performed via direct sequencing and comparison with the sequence retrieved from GenBank (GenBank accession no. HQ005425). The entire protein coding region of the ACTN3 gene was amplified by using 13 primer pairs, and 15 SNP loci were detected in the sequences of the 21 exons and surrounding genetic regions in the Yili horse. Among these SNPs, one was located in the promotor region (g.1104G>A), eight were exonic, and six were intronic ( Table 2 ). The following exonic SNPs were identified: E1 (g.3334G>A), which was located in the calponin homology domain; E2 (g.6206A>G), E3 (g.8608A>G), E4 (g.9059T>G), and E5 (g.9091C>G), which were located within spectrin repeats; and E6 (g.10660C>T), E7 (g.11304C>T), and E8 (g.11517A>G), which were located within two EF-hands [27] . The E4 SNP (g.9059T>G) was a missense mutation that led to a glycine-tocysteine change at position 594, whereas the other seven exonic SNPs were synonymous, and the encoded proteins had the same amino acid sequences. The observed heterozygosity, expected heterozygosity, and minor allele frequency of the alleles detected in the promoter and exon regions of the ACTN3 gene of 38 Yili horse were calculated (Table 3) . E2 (g.6206A>G) did not contain an AA sequence; E3 (g.8608A>G), E4 (g.9059T>G), and E5 (g.9091C>G) did not contain a GG sequence; E7 (g.11304C>T) had no TT sequence; and I1 (g.1104G>A), E1 (g.3334G>A), E6 (g.10660C>T), and E8 (g.11517A>G) had three genotypes. The Hardy-Weinberg equilibrium values (P > .05) of the mutations within the promoter and exon regions of the Yili horse were identified.
The results from the ACTN3 mRNA secondary structure prediction by RNAfold showed that (Fig. 2) the mutations in the exons slightly changed the secondary structure and the free energy of the thermodynamic ensemble from À1156.47 to À1159.85 kcal/mol ( Table 4) . The difference in the free energy of the thermodynamic ensemble leads to a difference in the stability of the RNA structure. Mutation E4 (g.9059T>G) led to changes in the secondary structure and free energy of the thermodynamic ensemble that may affect protein translation.
The results of the secondary structure prediction of a-actinin-3 protein by NPSAePRABI revealed that the E4 (g.9059T>G) mutation led to changes in the secondary structure of the protein, with an increase in the proportion of beta turns from 5.65% to 5.88%, a decrease in the proportion of alpha helices from 64.63% to 64.19%, an increase in the proportion of random coils from 19.29% to 19.40%, and an increase in the proportion of extended strands from 10.42% to 10.53% (Table 5) .
For the mutations in the promoter region and exons, the allele frequencies were not significantly different between the 1,000e2,000 m and 3,000e3,600 m groups of Yili horses. Interestingly, the G allele in E4 (g.9059T>G) and E5 (g.9091C>G) and the T allele in E6 (g. 10660C>T) were not detected in the 3,000e3,600 m group (Table 6 ).
Discussion
Cloning and sequencing of the full ACTN3 gene cDNA sequence offered clues into the functionality of this gene in the Yili horse and refined its current partial annotation. Whole amplification of genomic DNA from 38 Yili horses was used to sequence the entire ACTN3 coding region and the surrounding intron/exon boundaries for SNP discovery. Approximately 7535 bp of the ACTN3 gene were sequenced. The results of a previous study of a domestic horse population showed that an SNP was present in approximately every 644e891 bp [28] . In the present study, 8e12 SNPs were identified in the ACTN3 gene of the Yili horse. Fifteen SNPs were identified, which was close to the number identified in a previous study. Among these 15 SNPs, nine were identified in previous studies [24, 25] , and six were newly identified (E1 g.3334G>A, E3 g.8608A>G, E4 g.9059T>G, E5 g.9091C>G, I7 g.10636C>T, and E6 g.10660C>T). This difference may be caused by the variety induced in the breeding of Thoroughbred and Yili horses. The SNP g.1104G>A was located in the promoter region of the ACTN3 gene. This mutation, which was simulated with online software, may affect the expression of the equine ACTN3 gene, which could affect athletic performance. The homozygous AA genotype at position 1104 was not identified in Thoroughbreds, which are well known for short-distance racing, suggesting that the A allele could be detrimental to sprint performance [25] . However, this result was not confirmed in the present study. Hence, further studies are needed to determine the effect of this SNP on ACTN3 gene expression and the individual athletic performance of Yili horses.
Of the six SNPs identified in the intron regions, five were identified in previous studies [24, 25] , whereas the I7 g.10636C>T mutation was identified as a novel SNP in the ACTN3 gene of the Yili horse. Previous studies of gene polymorphisms mainly concentrated on cDNA. However, because these mutations were located within introns, which do not encode for protein, their effect on the amino acid sequence is unclear. Doron found no novel mutations in a software simulation [29] . Hence, further studies are needed to determine the potential effects of these mutations on protein structure and function.
Among the eight SNPs identified in the coding region, three were identified in previous studies [24, 25] , and five (E1 g.3334G>A, E3 g.8608A>G, E4 g.9059T>G, E5 g.9091C>G, and E6 g.10660C>T) were novel mutations. These SNPs corresponded to encoded amino acids, respectively, in the actin-binding domain (E1 and E2), central rod domain (E3, E4, E5, and E6), and EF hand domain (E7 and E8). The main physiological function of the actin-binding domain is actin binding via the Z-line proteins [30] , and phospholipid and phosphatidylinositol 4, 5-bisphosphate [31, 32] cross-linking maintain the integrity of the Z-lines and the subsequent stability of the muscle fiber structure [33] . The central rod domain is composed of four spectrin repeats, and the secondary structures of these spectrin repeats form three alpha helices [7] related to K þ protein interactions that affect glycolytic enzyme activity [34] . Once combined with Ca 2þ , the EF hand domain alters the dynamics of actin [35] and other proteins, which affects muscle fiber type [36] . This suggests that these mutations affect various aspects of aactinin-3 in the Yili horse, including muscle fiber structure, activation of signaling pathways, and oxidative metabolism, thereby influencing the athletic performance of the horse. Seven SNPs, which were synonymous mutations, caused no alteration in the amino acid sequence. It is unclear whether the changes in protein structure and function have any effect on athletic performance. Forecast analysis of the E4 (g.9059T>G) missense mutation using online software showed that the free energy of the mRNA thermodynamic ensemble increased, which led to reduced stability.
The amino acid at position 594 of a-actinin-3 was changed from a glycine to a cysteine (E4 g.9059T>G), and secondary structure prediction analysis showed that the change in the secondary structure of a-actinin-3 likely affected the tertiary structure, altering oxidase activity and ultimately athletic performance.
The structural, metabolic, signaling, and calcium handling changes observed in the ACTN3-KO mouse muscle provide a possible mechanistic explanation for the association between the ACTN3 genotype and athletic performance [37] . However, there has been relatively little research on horses. In this study, two-sided Fisher's exact tests of the allele frequencies of the SNPs in the promoter region and exons showed no significant differences in allele frequencies between the 1,000e2,000 m and 3,000e3,600 m groups. This may be owing to the small sample size examined. The G alleles at E4 (g.9059T>G) and E5 (g.9091C>G) and the T allele at E6 (g.10660C>T) was not detected in the 3,000e3,600 m group. Importantly, two horses with the E4 SNP (g.9059T>G) were faster than the others in the 1,000e2,000 m group. This suggests that the E4 SNP (g.9059T>G) may be related to the athletic performance of horses.
Conclusion
Of the 15 SNPs identified in the Yili horse, six SNPs have not been previously reported (g.3334G>A, g.8608A>G, g.9059T>G, g.9091C>G, g.10636G>T, and g.10660G>T), and one exonic SNP was a missense mutation (g.9059T>G). Biological analysis showed that this missense mutation caused a change in the mRNA secondary 
